Clinical Research Directory
Browse clinical research sites, groups, and studies.
Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty
Sponsor: Connecticut Children's Medical Center
Summary
The main question this randomized control trial aims to answer is: • Is the use of intraoperative subpectoral bupivacaine associated with decreased post-operative pain in adolescent patients who undergo bilateral reduction mammaplasty Participants will be randomized into the study group that intraoperatively receives 30cc of subpectoral bupivacaine injections or into the control group that intraoperatively receives 30cc of injectable saline subpectorally. All participants will keep a pain log and pain medication log at home for the first week following surgery. Researchers will compare to see if patients who receive subpectoral bupivacaine have lower pain scores in the PACU, and lower use of narcotics post-operatively when compared to the control group who receive injectable saline.
Key Details
Gender
All
Age Range
13 Years - 25 Years
Study Type
INTERVENTIONAL
Enrollment
128
Start Date
2022-04-01
Completion Date
2026-04-01
Last Updated
2025-05-29
Healthy Volunteers
Yes
Conditions
Interventions
Marcaine 0.25 % Injectable Solution
Patients in this arm will receive an injection of 20cc of injectable 0.25% bupivacaine solution. It will be injected in a fan-like pattern beneath the pectoralis fascia
Saline
Patients in this arm will receive an injection of 20cc of injectable saline. It will be injected in a fan-like pattern beneath the pectoralis fascia
Locations (2)
Connecticut Children's
Farmington, Connecticut, United States
Connecticut Children's
Hartford, Connecticut, United States